Driven to Do More

When you think of the word impact what does it mean to you? At Cogent Biosciences, it means real solutions. Every day, we come to work focused and driven by the opportunity to deliver the next best-in-class therapy for patients with genetically defined diseases – to move beyond incremental improvements and solely treating symptoms, to address the real causes of disease. We are methodical, rational, and intentional in our approach to identify pragmatic solutions to complex health challenges with the goal of restoring health and allowing patients to live better, longer lives.

Our Mission

To design rational precision therapies that treat the underlying cause of disease to improve patients’ lives.

Our Vision

To discover, develop, and commercialize best-in-class therapies that have a dramatic impact for patients with genetically defined diseases.

“Cogent Biosciences is dedicated to advancing a pipeline of precision therapies, starting with PLX9486, to improve outcomes for patients. Our therapies are designed to precisely and potently inhibit targets that drive genetic diseases.”

Chuck Wilson
Chief Executive Officer & President